Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center


CANDER S. , Dizdar O. S. , ÖZ GÜL Ö. , Guclu M., Unal O. K. , Tuncel E., ...More

PRIMARY CARE DIABETES, vol.8, no.3, pp.256-264, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 3
  • Publication Date: 2014
  • Doi Number: 10.1016/j.pcd.2014.01.010
  • Title of Journal : PRIMARY CARE DIABETES
  • Page Numbers: pp.256-264

Abstract

Aim: To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety.